Volunteer Assignments and Opportunities: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(69 intermediate revisions by 8 users not shown)
Line 1: Line 1:
Welcome!
Welcome!  


*For assignments, please see the "Author" column below.  If no name is present, volunteer to create content!
*We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books.  '''<u>If there is an entity not yet listed below that you would like to author in any WHO book, we would be happy to create a page for you now</u>'''.
*To volunteer, please '''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your page of interest.
*'''<u>NOTE: A new version of the Heme/Lymphoid book (5th edition) is in beta form on the WHO website with publication of a final form anticipated by mid-2023; we're working on a plan to align the related CCGA content to the new structure.</u>'''


__TOC__
We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books.  Please join the effort!   


==WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|complete
|
|Fabiola Quintero-Rivera (FQR)
|Date page was created
|
|-
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|Date page was created
|
|-
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|Date page was created
|
|-
|    Polycythaemia Vera  (PV)||Disease
|Gokce A. Toruner
|
|
|complete
|
|FQR
|
|
|-
|    Primary Myelofibrosis  (PMF)||Disease
|T. Niroshi  Senaratne
|
|
|complete
|
|FQR
|8/4/2020 before submission
|
|-
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith
|
|
|complete
|
|FQR
|
|8/1/21 FQR deleted "'''This page is under construction'''
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|Chelsea D. Kramish (trainee), Daynna J.Wolff
|
|
|complete/pending faculty review
|
|FQR
|
|
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Thomas Lee
|
|
|complete
|
|FQR
|
|
|-
|'''''Mastocytosis'''''||'''''Overview'''''||Shashi Shetty, Ph.D.
|
|
|complete
| ||FQR
|
|
|-
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung + Shuo-Shawn Liu (trainee)
|
|
|complete
|
|FQR
|
|8/1/21 FQR deleted "'''This page is under construction'''
|-
|    Systemic Mastocytosis||Disease
|Shashi Shetty
|
|
|complete
|
|FQR
|
|
|-
|    Mast Cell Sarcoma||Disease
|Thuy Phung +Jordan Lowery (trainee)
|
|
|complete
|
|FQR
|
|
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|
|
|complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
|
|
|Complete
|
|FQR
|
|NON-WHO ENTITY
|-
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
|
|
|Complete
|
|FQR
|
|NON-WHO ENTITY
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|9/1/20
|PENDING importing content and reference formatting
|
|FQR
|
|FQR has emailed SR several times, last 4/20/22
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|Date page was created
|
|-
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|
|
|complete
|
|FQR
|
|
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|4/21/22
|pending
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|complete
|
|FQR
|
|
|-
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|Complete
|
|FQR
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|
|
|Complete
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|04/26/2021 -MS (re-review)
|
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|
|
|''<s>PENDING</s> Complete - awaiting clarification''
| ||JH / MS
|04/26/2021 -MS (re-review)
|Review completed, awaiting some clarification from JH - 07/04/2022
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|03/01/2021-MS
|
|-
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
|
|
|Complete
|02/03/2021||JH / MS
|
|
|-
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|03/02/2021-MS
|
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|
|
|Complete
| ||JH / MS
|03/02/2021-MS (re-review)
|
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|
|
|Complete
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|
|
|Complete
|
|JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
|04/26/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|02/24/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|
|
|Complete
| ||JH / MS
|
|Need permission for figure?  Update WHO?
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg
Corboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu
|
|
|Complete
| ||JH / MS
|
|Add WHO reference
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Corboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|
|
|Complete
| ||JH / MS
|
|
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|
|
|Complete
| ||JH / MS
|
|Check reference format
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|
|
|Complete
| ||JH / MS
|
|
|-
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|
|
|Complete
| ||JH / MS
|
|
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
|
|
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|
|
|Complete
| ||JH / MS
|
|Need permission for figure?
|-
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
|
|
|-
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
|
|
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|
|
|Complete
| ||JH / MS
|
|
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|
|
|Complete
| ||JH / MS
|
|Check reference format
|-
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
|
|
|-
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|
|
|PENDING
| ||JH / MS
|
|
|-
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|
|
|PENDING
| ||JH / MS
|
|
|-
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Kay Weng Choy + Greg Corboy (Monash Health)
|
|
|Complete
|
|JH / MS
|
|NON-WHO ENTITY
|-
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|Disease
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|PENDING
|
|JH / MS
|
|NON-WHO ENTITY
|-
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|PENDING
|
|JH / MS
|
|NON-WHO ENTITY
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Yassmine Akkari (YA)
|
|
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|
|
|
| ||YA
|
|
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain (trainee) + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|
|
|PENDING
|
|YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +


Lisa Smith + Yassmine Akkari
To volunteer:  
|
 
|
#Select a link in the table to your book(s) of interest to view specific authorship opportunities.  Additional books are in the process of being added.
|Complete
#'''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your disease page of interest.  You will be connected with an Associate Editor to help guide you through the process.
|
#Complete the brief '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]''' to receive your log-in credentials. Information on [[Description of CCGA Roles|<u>Authorship and Other Roles</u>]] with the CCGA is available.
|YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|
|
|PENDING
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|
|
|PENDING
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|Complete
|
|YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease||Holli Drendel
|
|
|Complete
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|
|
|PENDING
| ||YA
|
|
|-
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Chenkai Ma
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|PENDING
| ||YA
|
|
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|2021 template added
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|2021 template added
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|SP
|
|
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Tsigab Bahta Hagos (trainee) / Shashirekha Shetty
|12/19/2022
|1/19/2023
|PENDING
|
|SP
|
|2021 template added
|-
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|SP
|
|2021 template added; No longer an entity
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|Lymphoplasmacytic Lymphoma||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
|
|
|PENDING review  by FQR
|
|SP
|
|2021 template added
|-
|   Waldenstrom  Macroglobulinemia||Disease||Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera
|
|
|PENDING review  by FQR
|
|SP
|
|2021 template added
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|    Mu Heavy Chain  Disease||Disease||
|
|
|
| ||SP
|
|
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|
|
|Complete
|5/26/2021||SP
|
|
|-
|    Alpha Heavy Chain  Disease||Disease||
|
|
|
| ||SP
|
|
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|PENDING
|
|SP
|
|
|-
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||Chen Yang, MD, PhD
|
|
|Complete
|09/10/2022||SP
|
|
|-
|           Primary  Amyloidosis||Disease||Heather E. Williams, PhD
|
|
|?PENDING
| ||SP
|
|
|-
|           Light Chain and Heavy Chain Deposition Disease||Disease||Chen Yang, MD, PhD
|
|
|Complete
|10/15/2022||SP
|
|
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||Sohini Anand
|8/31/2021
|9/15/2021
|PENDING
| ||SP
|
|
|-
|         POEMS Syndrome||Disease||Sohini Anand, MBBS, and Tharanga Niroshini Senaratne, PhD
|
|
|?PENDING
| ||SP
|
|
|-
|         TEMPI Syndrome||Disease||Sohini Anand, MBBS
|
|
|?PENDING
| ||SP
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee (trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|PENDING
|
|SP
|
|2021 template added
|-
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|Complete
|5/28/2021||SP
|
|
|-
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|11/11/2020
|SP
|
|
|-
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|-
|    Testicular Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|-
|    In Situ Follicular Neoplasia||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|-
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|8/16/2020
|SP
|
|
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|9/30/20
|Complete
|5/26/2021||SP
|
|
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|Complete
|09/10/2022
|SP
|
|
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|8/15/20
|PENDING
|
|SP
|
|
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Tsigab Hagos (trainee)/Shashirekha.Shetty
|12/19/2022
|1/19/2022
|Pending
|
|SP
|
|
|-
|    In Situ Mantle Cell Neoplasia||Disease||Rina Kansal, MD
|6/12/22
|
|Complete
|7/26/2022
|SP
|
|2021 template added
|-
| || ||
|
|
|
| ||
|
|
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|PENDING
|
|Greg Corboy (GC)
|
|Requested to update 14022022
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||Laveniya Satgunaseelan
|26/10/2021
|26/1/2022
|Complete
|03/28/22||GC
|03/28/22
|2021 template added
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
| ||GC
|
|
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|-
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
| ||GC
|
|
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|
|
|
| ||GC
|
|
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Lymphomatoid Granulomatosis||Disease||
|
|
|
| ||GC
|
|
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Intravascular Large B-cell Lymphoma||Disease||Kate Berry, Greg Corboy
|25/01/2022
|25/4/2022
|Complete
|9/1/22||GC
|9/1/22
|Emailed 28/3/2022 for progress update
|-
|ALK-Positive Large B-cell Lymphoma||Disease||Nakasaki Manando
|
|
|PENDING
| ||GC
|
|Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note).  2021 template added.
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|Complete
| ||GC
|28/03/2022
|
|-
|Primary Effusion Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|   Multicentric Castleman  Disease||Disease||Sudha Arumugam
|10/26/2021
|1/26/2022
|Complete
|24/01/2022||GC
|24/01/2022
|2021 template added
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Xiao Zhou, MD, PhD, Siparadigm
|10/26/2021
|1/26/2022
|PENDING
| ||GC
|
|Emailed 28/3/2022 for progress update
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||Xiao Zhou, MD, PhD, Siparadigm
|10/26/2021
|1/26/2022
|PENDING
| ||GC
|
|Emailed 28/3/2022 for progress update
|-
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|06/28/2021
|Complete
|28/06/2021||GC
|28/06/2021
|
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||Lauren Shealy (trainee), Daynna Wolff
|10/13/21
|01/13/2022
|Complete
|27/01/2022
|GC
|27/01/2021
|2021 template added
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||Kate Berry, Greg Corboy
|30/05/21
|30/08/21
|Complete
|24/02/2022||GC
|24/02/2022
|
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Aiko Otsubo, Holli Drendel
|7/30/21
|10/30/21
|Complete
|15/11/2021
|GC
|16/11/2021
|
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|-
|Aggressive NK-cell Leukemia||Disease||Shanelle De Lancy, MD, Shashirekha Shetty, PhD
|
|
|?PENDING
| ||SP
|
|
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|Complete
|11/21/2021||SP
|
|
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
| ||SP
|
|
|-
|    Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
| ||SP
|
|
|-
|    Severe Mosquito Bite  Allergy||Disease||
|
|
|
| ||SP
|
|
|-
|Adult T-cell Leukemia/Lymphoma||Disease||Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG
|
|
|?PENDING
| ||SP
|
|
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|Complete
|9/26/2022
|SP
|
|
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|Complete
|1/21/2021
|SP
|
|
|-
|     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|Complete
|9/26/2022
|SP
|
|
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|Complete
|1/21/2021
|SP
|
|
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|PENDING
| ||SP
|
|
|-
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee), Tingting Barrett (trainee)
|
|
|PENDING
| ||SP
|
|
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|    Lymphomatoid  Papulosis||Disease||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD
|
|
|PENDING
| ||SP
|
|
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||Peining Li, PhD
|
|
|PENDING
| ||SP
|
|
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|PENDING
| ||SP
|
|
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara / Miguel Gonzalez (trainee)
|
|
|Completed
|09/23/2022
|SP
|
|
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara  / Miguel Gonzalez (trainee)
|
|
|Completed
|09/23/2022
|SP
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
| ||Greg Corboy (GC)
|
|
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||Thomas Harrington (resident) + Daynna Wolff
|06/22/2022
|09/22/2022
|PENDING
| ||GC
|
|2021 template added, Daynna organising
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||Xiaolin (Lynn) Hu
|
|
|Completed
|03/21/22||GC
|03/21/22
|Edits sent 14022022
|-
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
|PENDING
| ||GC
|
|2021 template added
|-
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
|PENDING
| ||GC
|
|2021 template added
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
|PENDING
| ||GC
|
|2021 template added
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Lymphomas Associated with HIV Infection||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|11/2/21
|02/02/22
|Completed
|03/21/22
|GC
|03/21/22
|2021 template added
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Ania Shestakova (trainee) + Fabiola Quintero-Rivera
|
|
|completed
|april 2022
|GC
|26/4/2022
|
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Histiocytic Sarcoma||Disease||Marie-France Gagnon, MD, Mayo Clinic (LGG fellow trainee), Xinjie Xu, PhD FACMG, Mayo Clinic
|
|
|Complete
|10/01/2021
|GC
|10/01/2021
|Xinjie Xu
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|   Langerhans Cell  Histiocytosis||Disease||Malaika Perchard, Greg Corboy
|02/01/2022
|05/01/2022
|Complete
|04/28/2022||GC
|5/19/2022
|
|-
|   Langerhans Cell  Sarcoma||Disease||Malaika Perchard, Greg Corboy
|02/01/2022
|05/01/2022
|Complete
|04/28/2022||GC
|5/19/2022
|
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
| ||GC
|
|
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|-
|Erdheim-Chester Disease||Disease||Prashant Deshpande
|02/02/2022
|05/02/2022
|PENDING
| ||GC
|
|emailed 28/3/2022 to get update
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|}<br />


==WHO Classification of Soft Tissue and Bone Tumours (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
|2/20/2022
|
|PENDING
|
|Alanna Church
|
|
|-
|}<br />


==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content==
{| class="wikitable"
{| class="wikitable"
|+BOOKS WITH CONTENT IN PROGRESS
!Book Name
!Book Edition
!Book Acronym
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
|[[HAEM5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues]]
!'''Date Assigned to Author'''
|5th
!'''Target Completion Date'''
|HAEM5
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Astrocystoma, IDH-Mutant
|[[CNS5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Central Nervous System]]
|Disease
|5th
|Riley Lochner (trainee), Shashi Shetty (mentor)
|CNS5
|3/3/2022
|
|PENDING
|
|Laveniya Satgunaseelan (LS)
|
|2021 template added
|-
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
|[[GTS5:Volunteer Assignments and Opportunities|WHO Classification of Genetic Tumour Syndromes]]
|3/3/2022
|5th
|
|GTS5
|PENDING
|
|Laveniya Satgunaseelan (LS)
|
|2021 template added
|-
|-
|Glioblastoma, IDH-Wildtype||Disease||
|[[BRST5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Breast]]
|
|5th
|
|BRST5
|
|
|
|
|
|-
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||
|
|
|
|
|
|
|
|-
|Angiocentric Glioma||Disease||
|
|
|
|
|
|
|
|-
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Low-Grade Glioma,  MAPK Pathway-Altered||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Midline Glioma, H3  K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
|
|
|PENDING
|
|LS
|
|2021 template added
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
|2/21/2022
|
|PENDING
|
|LS
|
|2021 template added
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
|10/28/2022
|
|PENDING
|
|LS
|
|2021 template added
|-
|Infant-Type Hemispheric Glioma||Disease||
|
|
|
|
|
|
|2021 template added
|-
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
|9/13/2022<br />
|
|PENDING
|
|LS
|
|2021 template added
|-
|High-Grade Astrocytoma with Piloid Features||Disease||
|
|
|
|
|
|
|
|-
|Pleomorphic Xanthoastrocytoma||Disease||
|
|
|
|
|
|
|
|-
|Subependymal Giant Cell Astrocytoma||Disease||
|
|
|
|
|
|
|
|-
|Chordoid Glioma||Disease||
|
|
|
|
|
|
|
|-
|Astroblastoma, MN1-Altered||Disease||
|
|
|
|
|
|
|
|-
|Ganglioglioma||Disease||Leila Moayed-Aloei
|6/30/2022
|
|COMPLETE
|
|LS
|
|2021 template added
|-
|Gangliocytoma||Disease||
|
|
|
|
|
|
|
|-
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
|
|
|
|
|
|
|
|-
|Dysembryoplastic Neuroepithelial Tumour||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
|
|
|
|
|
|
|
|-
|Papillary Glioneuronal Tumour||Disease||
|
|
|
|
|
|
|
|-
|Rosette-Forming Glioneuronal Tumour||Disease||
|
|
|
|
|
|
|
|-
|Myxoid Glioneuronal Tumour||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
|
|
|
|
|
|
|
|-
|Multinodular and Vacuolating Neuronal Tumour||Disease||
|
|
|
|
|
|
|
|-
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
|
|
|
|
|
|
|
|-
|Central Neurocytoma||Disease||
|
|
|
|
|
|
|
|-
|Extraventricular Neurocytoma||Disease||
|
|
|
|
|
|
|
|-
|Cerebellar Liponeurocytoma||Disease||
|
|
|
|
|
|
|
|-
|Supratentorial Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
|
|
|
|
|
|
|
|-
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
|
|
|
|
|
|
|
|-
|Posterior Fossa Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Spinal Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Spinal Ependymoma, MYCN-Amplified||Disease||
|
|
|
|
|
|
|
|-
|Myxopapillary Ependymoma||Disease||
|
|
|
|
|
|
|
|-
|Subependymoma||Disease||
|
|
|
|
|
|
|
|-
|Choroid Plexus Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Atypical Choroid Plexus Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Choroid Plexus Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
|
|
|
|
|
|
|
|-
|Medulloblastoma, Histologically Defined||Disease||
|
|
|
|
|
|
|
|-
|Atypical Teratoid/Rhabdoid Tumour||Disease||
|
|
|
|
|
|
|
|-
|Cribriform Neuroepithelial Tumour||Disease||
|
|
|
|
|
|
|
|-
|Embryonal Tumour with Multilayered Rosettes||Disease||
|
|
|
|
|
|
|
|-
|CNS Neuroblastoma, FOXR2-Activated||Disease||
|
|
|
|
|
|
|
|-
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
|
|
|
|
|
|
|
|-
|CNS Embryonal Tumour NEC/NOS||Disease||
|
|
|
|
|
|
|
|-
|Pineocytoma||Disease||
|
|
|
|
|
|
|
|-
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
|
|
|
|
|
|
|
|-
|Pineoblastoma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Tumour of the Pineal Region||Disease||
|
|
|
|
|
|
|
|-
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
|
|
|
|
|
|
|
|-
|Schwannoma||Disease||
|
|
|
|
|
|
|
|-
|Neurofibroma||Disease||
|
|
|
|
|
|
|
|-
|Perineurioma||Disease||
|
|
|
|
|
|
|
|-
|Hybrid Nerve Sheath Tumours||Disease||
|
|
|
|
|
|
|
|-
|Malignant Melanotic Nerve Sheath Tumour||Disease||
|
|
|
|
|
|
|
|-
|Malignant Peripheral Nerve Sheath Tumour||Disease||
|
|
|
|
|
|
|
|-
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
|
|
|
|
|
|
|
|-
|Meningioma||Disease||
|
|
|
|
|
|
|
|-
|Solitary Fibrous Tumour||Disease||
|
|
|
|
|
|
|
|-
|Haemangiomas and Vascular Malformations||Disease||
|
|
|
|
|
|
|
|-
|Haemangioblastoma||Disease||
|
|
|
|
|
|
|
|-
|Rhabdomyosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
|
|
|
|
|
|
|
|-
|CIC-Rearranged Sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
|
|
|
|
|
|
|
|-
|Ewing Sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Mesenchymal Chondrosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Chondrosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Chordoma||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
|
|
|
|
|
|
|
|-
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
|
|
|
|
|
|
|
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Immunodeficiency-Associated CNS Lymphomas||Disease||
|
|
|
|
|
|
|
|-
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
|
|
|
|-
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|MALT Lymphoma of the Dura||Disease||
|
|
|
|
|
|
|
|-
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||
|
|
|
|
|
|
|
|-
|T-cell and NK/T-cell Lymphomas||Disease||
|
|
|
|
|
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
|
|
|
|
|-
|Rosai-Dorfman Disease||Disease||
|
|
|
|
|
|
|
|-
|Juvenile Xanthogranuloma||Disease||
|
|
|
|
|
|
|
|-
|Langerhans Cell Histiocytosis||Disease||
|
|
|
|
|
|
|
|-
|Histiocytic Sarcoma||Disease||
|
|
|
|
|
|
|
|-
|Germ Cell Tumours of the CNS||Disease||
|
|
|
|
|
|
|
|-
|Adamantinomatous Craniopharyngioma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Craniopharyngioma||Disease||
|
|
|
|
|
|
|
|-
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
|
|
|
|
|
|
|
|-
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
|
|
|
|
|
|
|
|-
|Pituitary Blastoma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Meninges||Disease||
|
|
|
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||
|
|
|
|
|
|
|
|-
|Neurofibromatosis Type 2||Disease||
|
|
|
|
|
|
|
|-
|Schwannomatosis||Disease||
|
|
|
|
|
|
|
|-
|Von Hippel-Lindau Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Tuberous Sclerosis||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Cowden Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Familial Adenomatous Polyposis 1||Disease||
|
|
|
|
|
|
|
|-
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Rhabdoid Tumour Predisposition Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Carney Complex||Disease||
|
|
|
|
|
|
|
|-
|DICER1 Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Familial Paraganglioma Syndromes||Disease||
|
|
|
|
|
|
|
|-
|Melanoma-Astrocytoma Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Familial Retinoblastoma||Disease||
|
|
|
|
|
|
|
|-
|BAP1 Tumour Predisposition Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Fanconi Anaemia||Disease||
|
|
|
|
|
|
|
|-
|ELP1-Medulloblastoma Syndrome||Disease||
|
|
|
|
|
|
|
|-
|}<br />
==WHO Classification of Tumours of Breast Tumours (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|- |Usual ductal hyperplasia||Disease||
|Usual Ductal Hyperplasia
|Disease
|
|
|
|
|
|-
|Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease||
|
|
|
|
|
|
|
|-
|Atypical Ductal Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Sclerosing Adenosis||Disease||
|
|
|
|
|
|
|
|-
|Apocrine Adenosis and Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Microglandular Adenosis||Disease||
|
|
|
|
|
|
|
|-
|Radial Scar/Complex Sclerosing Lesion||Disease||
|
|
|
|
|
|
|
|-
|Tubular Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Lactating Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Ductal Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Pleomorphic Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Adenomyoepithelioma||Disease||
|
|
|
|
|
|
|
|-
|Malignant Adenomyoepithelioma||Disease||
|
|
|
|
|
|
|
|-
|Intraductal Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Ductal Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Encapsulated Papillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Solid Papillary Carcinoma (In Situ and Invasive)||Disease||
|
|
|
|
|
|
|
|-
|Invasive Papillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Atypical Lobular Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Lobular Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Ductal Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Invasive Breast Carcinoma of No Special Type||Disease||
|
|
|
|
|
|
|
|-
|Microinvasive Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Invasive lobular Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Tubular Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Cribriform Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Mucinous Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Mucinous Cystadenocarcinoma||Disease||
|
|
|
|
|
|
|
|-
|Invasive Micropapillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Carcinoma with Apocrine Differentiation||Disease||
|
|
|
|
|
|
|
|-
|Metaplastic Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Acinic Cell Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach
|10/12/02022
|
|PENDING
|
|Hui Chen
|
|2021 template added
|-
|Secretory Carcinoma||Disease||Hui Chen
|10/12/2022
|
|PENDING
|
|Katherine Geiersbach
|
|2021 template added
|-
|Mucoepidermoid Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Polymorphous Adenocarcinoma||Disease||
|
|
|
|
|
|
|
|-
|Tall Cell Carcinoma with Reversed Polarity||Disease||
|
|
|
|
|
|
|
|-
|Neuroendocrine Tumour||Disease||
|
|
|
|
|
|
|
|-
|Neuroendocrine Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Hamartoma||Disease||
|
|
|
|
|
|
|
|-
|Fibroadenoma||Disease||
|
|
|
|
|
|
|
|-
|Phyllodes Tumour||Disease||
|
|
|
|
|
|
|
|-
|Syringomatous Tumour||Disease||
|
|
|
|
|
|
|
|-
|Nipple Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Paget disease of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Haemangioma||Disease||
|
|
|
|
|
|
|
|-
|Angiomatosis||Disease||
|
|
|
|
|
|
|
|-
|Atypical Vascular Lesions||Disease||
|
|
|
|
|
|
|
|-
|Postradiation Angiosarcoma of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Primary Angiosarcoma of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Nodular Fasciitis||Disease||
|
|
|
|
|
|
|
|-
|Myofibroblastoma||Disease||
|
|
|
|
|
|
|
|-
|Desmoid Fibromatosis||Disease||
|
|
|
|
|
|
|
|-
|Inflammatory Myofibroblastic Tumour||Disease||
|
|
|
|
|
|
|
|-
|Schwannoma||Disease||
|
|
|
|
|
|
|
|-
|Neurofibroma||Disease||
|
|
|
|
|
|
|
|-
|Granular Cell Tumour||Disease||
|
|
|
|
|
|
|
|-
|Leiomyoma||Disease||
|
|
|
|
|
|
|
|-
|Leiomyosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Lipoma||Disease||
|
|
|
|
|
|
|
|-
|Angiolipoma||Disease||
|
|
|
|
|
|
|
|-
|Liposarcoma||Disease||
|
|
|
|
|
|
|
|-
|Pseudoangiomatous Stromal Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
|
|
|
|
|
|
|
|-
|Follicular Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Burkitt Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Gynaecomastia||Disease||
|
|
|
|
|
|
|
|-
|Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Invasive Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Breast||Disease||
|
|
|
|
|
|
|
|-
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Cowden Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Ataxia-Telangiectasia||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni Syndrome, TP53-Associated||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni Syndrome, CHEK2-Associated||Disease||
|
|
|
|
|
|
|
|-
|CDH1-Associated Breast Cancer||Disease||
|
|
|
|
|
|
|
|-
|PALB2-Associated Cancers||Disease||
|
|
|
|
|
|
|
|-
|Peutz-Jeghers Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||
|
|
|
|
|
|
|
|-
|Polygenic Component of Breast Cancer Susceptibility
|Disease
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Volunteer Assignments and Opportunities|WHO Classification of Soft Tissue and Bone Tumours]]
|5th
|STBT5
|}
|}


==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
 
{| class="wikitable sortable"
{| class="wikitable"
!'''Gene'''
|+BOOKS COMING SOON
!'''Author'''
!Book Name
!'''Date Assigned to Author'''
!Book Edition
!'''Target Completion Date'''
!Book Acronym
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|BCR
|Brian Davis
|
|
|Complete
|8/10/18
|
|
|
|-
|ABL1
|Brian Davis
|
|
|Complete
|4/16/19
|
|
|
|-
|RUNX1
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|RUNX1T1
|Brian Davis
|
|
|Complete
|5/23/19
|
|
|
|-
|MYH11
|Brian Davis
|
|
|Complete
|8/6/18
|
|
|
|-
|FLT3
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|NPM1
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|TP53
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|DNMT3A
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|CEBPA
|Gordana
|
|
|Complete
|
|
|
|
|-
|IDH1
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|IDH2
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|PML
|Brian Davis
|
|
|Complete
|12/5/18
|
|
|
|-
|RARA
|Brian Davis
|
|
|Complete
|8/3/18
|
|
|
|-
|ETV6
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|KIT
|Brian Davis
|
|
|Complete
|10/1/18
|
|
|
|-
|CBFB
|Brian Davis
|
|
|Complete
|8/2/18
|
|
|
|-
|GATA2
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|PTEN
|Beth Pitel
|
|
|Pending
|
|
|
|
|-
|MLTT3
|
|
|
|
|
|
|
|
|-
|MECOM
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|FGFR1(FLT2)
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|KMT2A
|
|
|
|
|
|
|
|
|-
|DEK
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|-
|NUP214
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|-
|RBM15
|
|
|
|
|
|
|
|
|-
|MKL1
|
|
|
|
|
|
|
|
|-
|DDX41
|Ying Zou
|8/7/20
|
|Pending
|
|
|
|
|-
|ANKRD26
|
|
|
|
|
|
|
|
|-
|CUX1
|
|
|
|
|
|
|
|
|-
|TET2
|
|
|
|
|
|
|
|
|-
|EZH2
|
|
|
|
|
|
|
|
|-
|FOXP1
|
|
|
|
|
|
|
|
|-
|MYC
|
|
|
|
|
|
|
|
|-
|JAK2
|
|
|
|
|
|
|
|
|-
|WT1
|DONE
|
|
|DONE
|
|
|
|
|-
|CBL
|
|
|
|
|
|
|
|
|-
|NF1
|
|
|
|
|
|
|
|
|-
|SUZ12
|
|
|
|
|
|
|
|
|-
|ERG
|
|
|
|
|
|
|
|
|-
|EST2
|
|
|
|
|
|
|
|
|-
|RPS14
|
|
|
|
|
|
|
|
|-
|RB1
|
|
|
|
|
|
|
|
|-
|MPL
|
|
|
|
|
|
|
|
|-
|CHGA
|
|
|
|
|
|
|
|
|-
|CDH1
|
|
|
|
|
|
|
|
|-
|SRSF2
|
|
|
|
|
|
|
|
|-
|DNMT1
|
|
|
|
|
|
|
|
|-
|PRDX2
|
|
|
|
|
|
|
|
|-
|-
|ASXL1
|[[DIG5:Volunteer Assignments and Opportunities|WHO Classification of Digestive System Tumours]]
|DONE
|5th
|
|DIG5
|
|DONE
|
|
|
|
|-
|-
|MN1
|[[EYE5:Volunteer Assignments and Opportunities|WHO Classification of Eye and Orbit Tumours]]
|
|5th
|
|EYE5
|
|
|
|
|
|
|-
|-
|SF3A1
|[[SKIN5:Volunteer Assignments and Opportunities|WHO Classification of Skin Tumours]]
|
|5th
|
|SKIN5
|
|
|
|
|
|
|-
|-
|EP300
|[[HAN5:Volunteer Assignments and Opportunities|WHO Classification of Head and Neck Tumours]]
|
|5th
|
|HAN5
|
|
|
|
|
|
|-
|-
|JARID2
|[[ENDO5:Volunteer Assignments and Opportunities|WHO Classification of Endocrine and Neuroendocrine Tumours]]
|
|5th
|
|ENDO5
|
|
|
|
|
|
|-
|-
|BRCA1
|[[MALE5:Volunteer Assignments and Opportunities|WHO Classification of Urinary and Male Genital Tumours]]
|
|5th
|
|MALE5
|
|
|
|
|
|
|-
|-
|BRCA2
|[[PEDS5:Volunteer Assignments and Opportunities|WHO Classification of Paediatric Tumours]]
|
|5th
|
|PEDS5
|
|
|
|
|
|
|-
|-
|
|[[THOR5:Volunteer Assignments and Opportunities|WHO Classification of Thoracic Tumours]]
|
|5th
|
|THOR5
|
|
|
|
|
|
|-
|-
|
|[[FEMA5:Volunteer Assignments and Opportunities|WHO Classification of Female Genital Tumours]]
|
|5th
|
|FEMA5
|
|
|
|
|
|
|}
|}

Latest revision as of 12:29, 27 June 2024

Welcome!


We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books. Please join the effort!


To volunteer:

  1. Select a link in the table to your book(s) of interest to view specific authorship opportunities. Additional books are in the process of being added.
  2. Contact us with your disease page of interest. You will be connected with an Associate Editor to help guide you through the process.
  3. Complete the brief Volunteer Form to receive your log-in credentials. Information on Authorship and Other Roles with the CCGA is available.


BOOKS WITH CONTENT IN PROGRESS
Book Name Book Edition Book Acronym
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 5th HAEM5
WHO Classification of Tumours of the Central Nervous System 5th CNS5
WHO Classification of Genetic Tumour Syndromes 5th GTS5
WHO Classification of Tumours of the Breast 5th BRST5
WHO Classification of Soft Tissue and Bone Tumours 5th STBT5


BOOKS COMING SOON
Book Name Book Edition Book Acronym
WHO Classification of Digestive System Tumours 5th DIG5
WHO Classification of Eye and Orbit Tumours 5th EYE5
WHO Classification of Skin Tumours 5th SKIN5
WHO Classification of Head and Neck Tumours 5th HAN5
WHO Classification of Endocrine and Neuroendocrine Tumours 5th ENDO5
WHO Classification of Urinary and Male Genital Tumours 5th MALE5
WHO Classification of Paediatric Tumours 5th PEDS5
WHO Classification of Thoracic Tumours 5th THOR5
WHO Classification of Female Genital Tumours 5th FEMA5
Retrieved from "https://test.ccga.io/index.php?title=Volunteer_Assignments_and_Opportunities&oldid=14522"